Masato Fujisawa

Kobe University

Papers

1

Total Citations

4

H-Index

1

About

Masato Fujisawa is a urological researcher whose work centers on the treatment of benign prostatic hyperplasia (BPH) and the management of lower urinary tract symptoms (LUTS). His research focuses on evaluating innovative robotic and minimally invasive surgical technologies, with a particular emphasis on assessing their safety, efficacy, and patient-reported outcomes in clinical settings. Fujisawa's most notable contribution to date includes a 2024 post-market use-results survey examining Aquablation therapy using the AQUABEAM Robotic System in a Japanese patient population — a study that represents an important step in validating cutting-edge robotic urological interventions within an Asian clinical context. This work addresses a significant gap in the literature by capturing real-world outcomes specific to Japanese patients, a demographic that has been underrepresented in large-scale BPH intervention studies. While Fujisawa's citation record is still developing, with his leading publication already accumulating citations within its first year, his research agenda positions him as an emerging voice in urological innovation, contributing meaningfully to the global conversation around personalized, technology-driven approaches to prostate disease management.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
AQUABEAM robotic system use‐results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Kobe University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago